Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18,270 KRW | +6.22% | +2.30% | +37.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.89% | 981M | |
+12.11% | 108B | |
-2.60% | 30B | |
+6.15% | 21.06B | |
-12.82% | 18.45B | |
-11.98% | 16.3B | |
+10.06% | 15.47B | |
+4.96% | 12.84B | |
+0.53% | 11.02B | |
+11.78% | 8.37B |
- Stock Market
- Equities
- A336370 Stock
- News Solus Advanced Materials Co., Ltd.
- Croda International Plc agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. for KRW350 billion.